Prosecution Insights
Last updated: April 19, 2026

Ranok Therapeutics (Hangzhou) Co. Ltd.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
0
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18196454 INHIBITORS OF KRAS(G12D) SEITZ, ANTHONY JOSEPH 1629 Non-Final OA May 12, 2023
18031701 METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION LADD, CAROLYN LOUISE 1622 Non-Final OA Apr 13, 2023
18031678 METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION WILLIS, DOUGLAS M 1624 Non-Final OA Apr 13, 2023
18031679 METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION NOLAN, JASON MICHAEL 1623 Non-Final OA Apr 13, 2023

Managing Ranok Therapeutics (Hangzhou) Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month